GlassScriptPhysician profile
Melissa M Halbach
NPI 1962570747
$3,348.77
in general payments reported to CMS, 2019-2025
25 companies · $678 in 2025
The $678 reported for 2025 was more than what 86% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $435 · 2020: $368 · 2021: $316 · 2022: $524 · 2023: $610 · 2024: $418 · 2025: $678.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,661 · Education: $45.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,661.05 |
| Education | $45.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $726.52 | 2019-2025 | |
| Abbvie INC. | $439.57 | 2019-2025 | |
| Astellas Pharma US INC | $334.76 | 2023-2025 | Veozah, Myrbetriq |
| Boston Scientific Corporation | $199.29 | 2019-2025 | Varithena Administration Pack, General - Pain Management |
| Mayne Pharma Commercial LLC | $193.93 | 2021-2025 | |
| Biogen, INC. | $192.38 | 2024-2025 | Zurzuvae |
| Sumitomo Pharma America, INC. | $167.62 | 2023-2025 | Myfembree |
| Exeltis, USA INC. | $137.58 | 2022-2025 | Slynd |
| Coopersurgical, INC. | $115.80 | 2019-2024 | Paragard T 380a, Paragard T 380a |
| Organon LLC | $111.52 | 2022-2025 | Nexplanon |
| Merck Sharp & Dohme LLC | $108.51 | 2019-2025 | Gardasil 9, Gardasil |
| Millicent US INC | $100.39 | 2025 | Intrarosa, Femlyv, Femring |
| Myovant Sciences INC. | $72.81 | 2022 | |
| Hologic Sales and Service, LLC | $69.46 | 2019-2023 | Aptima |
| Pfizer INC. | $58.53 | 2019-2023 |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lupin INC. | $53.76 | 2019-2020 | |
| Medtronic, INC. | $44.64 | 2022-2023 | Endo Stitch, Ligasure |
| Therapeuticsmd, INC. | $42.84 | 2020-2022 | |
| Allergan, INC. | $42.69 | 2019-2020 | |
| Amgen INC. | $30.32 | 2019-2020 | |
| Roche Diagnostics Corporation | $29.27 | 2019 | |
| Avion Pharmaceuticals | $29.08 | 2019-2022 | |
| Ethicon US, LLC | $17.67 | 2019 | |
| Radius Health, INC. | $15.94 | 2019 | |
| Mimedx Group, INC. | $13.89 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Melissa Halbach listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.